Related Experiment Video

Updated: Jun 13, 2026

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
07:15

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

The RV144 Thai HIV vaccine trial

Stanley A Plotkin

    Human Vaccines
    |May 1, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

    Published on: January 26, 2019

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
    13:36

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

    Published on: May 6, 2015

    Related Experiment Videos

    Last Updated: Jun 13, 2026

    Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
    07:15

    Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

    Published on: November 22, 2021

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

    Published on: January 26, 2019

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
    13:36

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

    Published on: May 6, 2015

    Related Concept Videos

    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

    Articles linked to this work by shared authors, journal, and citation graph.

    A vaccine against cytomegalovirus: how close are we?

    The Journal of clinical investigation·2025

    The Current and Future State of Vaccines for Lyme Disease.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

    Beyond Awareness: Hope for a CMV Vaccine! An Introduction to the Conference, "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).

    Vaccines·2024

    Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).

    Vaccines·2024

    Structure-based design of glycoprotein subunit vaccines for mumps.

    Proceedings of the National Academy of Sciences of the United States of America·2024

    Vaccine Development Should Be Polytheistic, Not Monotheistic.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

    Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.

    Human vaccines·2012

    Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?

    Human vaccines·2011

    Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.

    Human vaccines·2011

    Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.

    Human vaccines·2011

    Fighting against infectious diseases in China.

    Human vaccines·2011

    Hepatitis B Vaccine in national immunization schedule: a preventive step in India.

    Human vaccines·2011

    Unique Human Intestinal Tuft Cell Features Revealed by Pluripotent Stem Cell-Derived Mini-Guts.

    Gastro hep advances·2026

    Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis.

    Frontiers in bioinformatics·2026

    Case Report: Concurrent thyroid tuberculosis and tuberculous lymphadenitis initially misdiagnosed as malignancy by 18F-FDG PET/CT.

    Frontiers in surgery·2026

    The Right Key, the Wrong Lock: TIGIT Checkpoint Blockade and the Road to Precision Immunotherapy.

    Pharmaceutics·2026

    Spatial Immune Coding in Tumor-Draining Lymph Nodes: Functional Compartmentalization of Immune Activation and Immunosuppression.

    International journal of molecular sciences·2026

    Immune Checkpoint Inhibitor-Induced Vogt-Koyanagi-Harada-like Disease Complicated by Inflammatory Macular Neovascularisation: A Case Report and Literature Review.

    Diagnostics (Basel, Switzerland)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us